Bessemer Group Inc Immunity Bio, Inc. Transaction History
Bessemer Group Inc
- $60.7 Billion
- Q3 2024
A detailed history of Bessemer Group Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 50 shares of IBRX stock, worth $224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$224
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
202Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$75.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$51.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$38.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$17.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.8B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...